Variant report
Variant | esv3376378 |
---|---|
Chromosome Location | chr8:1412149-1413149 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:1407170..1410057-chr8:1410241..1414268,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186622576 | chr8:1412177-1412178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs539404730 | chr8:1412178-1412179 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116388571 | chr8:1412181-1412182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534640850 | chr8:1412222-1412223 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572969320 | chr8:1412226-1412227 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs115512286 | chr8:1412235-1412236 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143150765 | chr8:1412247-1412248 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs191420108 | chr8:1412248-1412249 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73672722 | chr8:1412249-1412250 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs535284284 | chr8:1412262-1412263 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544878998 | chr8:1412295-1412296 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147688314 | chr8:1412296-1412297 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs578196882 | chr8:1412305-1412306 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201156046 | chr8:1412307-1412308 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79092104 | chr8:1412313-1412314 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539817733 | chr8:1412315-1412316 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112244107 | chr8:1412323-1412324 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528977026 | chr8:1412326-1412327 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74547392 | chr8:1412334-1412335 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549148305 | chr8:1412336-1412337 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs79073338 | chr8:1412337-1412338 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs79601116 | chr8:1412345-1412346 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562665344 | chr8:1412347-1412348 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs77487721 | chr8:1412357-1412358 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531367049 | chr8:1412358-1412359 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs372674243 | chr8:1412370-1412371 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551556605 | chr8:1412374-1412375 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs202044396 | chr8:1412385-1412386 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs78187477 | chr8:1412386-1412387 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs200969034 | chr8:1412389-1412390 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs571423762 | chr8:1412393-1412394 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201986242 | chr8:1412396-1412397 | ZNF genes & repeats Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373340197 | chr8:1412400-1412401 | ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs200443459 | chr8:1412401-1412402 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs78907793 | chr8:1412402-1412403 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs202034904 | chr8:1412417-1412418 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73534673 | chr8:1412418-1412419 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs79555624 | chr8:1412421-1412422 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74449427 | chr8:1412434-1412435 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370672153 | chr8:1412435-1412436 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs80041431 | chr8:1412438-1412439 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs74193927 | chr8:1412453-1412454 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs151232425 | chr8:1412465-1412466 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372831392 | chr8:1412469-1412470 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375913415 | chr8:1412476-1412477 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs77534150 | chr8:1412482-1412483 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs72507645 | chr8:1412485-1412486 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs74354693 | chr8:1412498-1412499 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs74728762 | chr8:1412501-1412502 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs372124804 | chr8:1412509-1412510 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital diaphragmatic hernia | 21341218 | CNVD |
Cancer | 18840272 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Autism | 20531469 | CNVD |
Breast cancer | 20932292 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Ependymoma | 20639864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:1405200-1412200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:1410800-1412200 | Enhancers | Left Ventricle | heart |
3 | chr8:1410800-1412400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
4 | chr8:1411600-1416000 | Enhancers | Spleen | Spleen |
5 | chr8:1411800-1412200 | Enhancers | Adipose Nuclei | Adipose |
6 | chr8:1411800-1413000 | Enhancers | Right Ventricle | heart |
7 | chr8:1412000-1412600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
8 | chr8:1412200-1412400 | Bivalent Enhancer | Adipose Nuclei | Adipose |
9 | chr8:1412200-1412600 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
10 | chr8:1412200-1412600 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
11 | chr8:1412200-1412600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
12 | chr8:1412200-1412800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr8:1412200-1412800 | Weak transcription | Left Ventricle | heart |
14 | chr8:1412400-1412600 | Flanking Bivalent TSS/Enh | Adipose Nuclei | Adipose |
15 | chr8:1412400-1412600 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
16 | chr8:1412400-1412800 | Flanking Active TSS | Skeletal Muscle Male | skeletal muscle |
17 | chr8:1412400-1413000 | Enhancers | Pancreas | Pancrea |
18 | chr8:1412600-1413000 | Bivalent/Poised TSS | Adipose Nuclei | Adipose |
19 | chr8:1412600-1413600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
20 | chr8:1412600-1413800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
21 | chr8:1412600-1416400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
22 | chr8:1412800-1413000 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
23 | chr8:1412800-1413000 | Enhancers | Left Ventricle | heart |
24 | chr8:1412800-1413000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
25 | chr8:1412800-1415400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
26 | chr8:1413000-1414200 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
27 | chr8:1413000-1414400 | Weak transcription | Pancreas | Pancrea |